Quality of life assessment among leprosy patients residing at leprosy home in a district of Eastern Odisha: a cross-sectional study
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20261770Keywords:
Leprosy, Quality of life, WHOQOL-BREF, Disability, StigmaAbstract
Background: Leprosy remains a significant public health concern in India, contributing substantially to disability, stigma, and impaired quality of life (QoL), despite its elimination as a public health problem. Persons affected by leprosy often experience long-term physical, psychological, and social consequences, particularly those with visible disabilities. This study aimed to assess the quality of life and patterns of disability among leprosy-affected persons residing in a leprosy care and rehabilitation centre in a district of Eastern Odisha.
Methods: A cross-sectional study was conducted in December 2024 among 80 adult leprosy patients residing at the Leprosy Care and Rehabilitation Centre, Cuttack, using universal sampling. Sociodemographic details and disability grades were recorded. QoL was assessed using the WHOQOL-BREF questionnaire. Domain-wise transformed scores were calculated, and data were analyzed using SPSS version 17. Statistical significance was set at p<0.05.
Results: Of the 80 participants, 64% were male and the mean age was 56.6±18.2 years. A majority (87%) had Grade 2 disability. The lowest QoL scores were observed in the social and psychological domains. Overall, 62% of participants rated their quality of life as poor or very poor. Male gender, younger age, higher education, better socioeconomic status, unmarried status, and contact with family were significantly associated with better QoL in one or more domains.
Conclusions: Leprosy continues to severely compromise quality of life, particularly in the social and psychological domains, among affected individuals in Eastern Odisha. Comprehensive rehabilitation, stigma reduction, psychosocial support, and family-centered interventions are essential alongside medical management to improve overall well-being.
References
Clinico-epidemiological and histopathological study of newly diagnosed leprosy patients at tertiary care center. Available at: https://www.researchgate.net/publication/347366731_Clinicoepidemiological_and_histopathological_study_of_newly_diagnosed_leprosy_patients_at_tertiary_care_center. Accessed on 07 January 2026.
Reis FJJ, Cunha AJLA, Gosling AP, Fontana AP, Gomes MK. Quality of life and its domains in leprosy patients after neurolysis: a study using WHOQOL-BREF. Lepr Rev. 2013;84(2):119-23.
Savassi LCM, Bogutchi TRS, Lima ACL, Modena CM. Quality of life of leprosy sequelae patients living in a former leprosarium under home care: univariate analysis. Qual Life Res. 2014;23(4):1345-51.
WHO. Health promotion glossary. Geneva: World Health Organization. 1998. Available at: https://www.who.int/publications/i/item/WHO-HPR-HEP-98.1. Accessed on 07 January 2026.
Stigma Related to Leprosy – A Scientific View. International Textbook of Leprosy. Available at: https://internationaltextbookofleprosy.org//chapter/Stigma Related to Leprosy – A Scientific View. Accessed on 07 January 2026.
Geetha K, Dhanalakshmi A, Judie A. A study to assess the impact of leprosy on quality of life among leprosy patients in Government Rehabilitation Home at Paranur. Int J Pharm Clin Res. 2015;7(6):466-8.
NLEP. New Delhi: Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India. 2025. Available at: https://dghs.mohfw.gov.in/nlep.php. Accessed on 07 January 2026.
Jaypee Brothers Medical Publishers. DK Taneja’s Health Policies and Programmes in India. New Delhi: Jaypee Brothers Medical Publishers. 2025.
WHO. WHOQOL-BREF. Geneva: World Health Organization. 2026. Available at: https://www.who.int/tools/whoqol/whoqol-bref. Accessed on 07 January 2026.
WHO BREF calculation.pdf. World Health Organization. WHOQOL-BREF: introduction, administration, scoring and generic version of the assessment: field trial version, December 1996. Geneva: World Health Organization; 1996. Available at: https://iris.who.int/handle/ 10665/63529. Accessed on 26 May 2026.
Kumar U, Varma K, Baraithiya K. Clinico-epidemiological and histopathological study of newly diagnosed leprosy patients at tertiary care center. IP Indian J Clin Exp Dermatol. 2025;6(4):374-81.
Pai V, Vhora S, Shukla P, Navya A. Quality of life in patients with leprosy using WHOQOL-BREF questionnaire: a pilot study. Indian J Lepr. 2022;94:197-206.
Das NK, De A, Naskar B, Sil A, Das S, Sarda A, et al. A Quality of Life Study of Patients with Leprosy Attending the Dermatology OPD of a Tertiary Care Center of Eastern India. Indian J Dermatol. 2020;65(1):42-6.
Govindharaj P, Srinivasan S, Darlong J. Quality of life of persons affected by leprosy in an endemic district, West Bengal, India. Indian J Dermatol. 2018;63(6):459-64.
Belgaumkar VA, Sodhi B, Patil PP, Bhatt N. Impact of leprosy on the quality of life in India: a decade post-elimination. J Skin Stem Cell. 2021;8(3):e120879.
Solanki AD, Barot JP, Patel JH, Patel NM, Patel D, Nagrani N, et al. Measurement of quality of life in patients of leprosy attending outdoor patient department at tertiary care center of Ahmedabad: a cross-sectional study. Indian J Lepr. 2020;92:139-45.
Noordende AT van’t, Pereira ZB da S, Biswas P, Ilyas M, Krishnan V, Parasa J, et al. Strengthening individual and family resilience against leprosy-related discrimination: A pilot intervention study. PLOS Negl Trop Dis. 2021;15(4):e0009329.